Topic
Longevity
Healthspan, biological aging, and decisions whose payoff is decades.
Evelyn CrossThe Case for Taurine: When a Molecule Crosses from Observation to Intervention
Blood levels of taurine drop by roughly eighty percent between early life and age sixty. In longevity research, we routinely observe molecules that plummet as we age, but we know that correlation is rarely causation.…
Evelyn CrossThe Longevity Molecule Hiding in Plain Sight
We spend a lot of time analyzing complex epigenetic reprogramming and expensive senolytics. Yet, one of the most compelling recent findings in aging biology revolves around taurine, a cheap, semi-essential amino acid.…
Evelyn CrossThe Case for Taurine: A Boring Molecule With Extraordinary Lifespan Data
For decades, taurine has suffered a branding problem, relegated to the neon cans of gas station energy drinks. But in longevity research, we care about data, not marketing. A landmark 2023 study published in Science f…
Evelyn CrossThe Expected Value of Taurine in the Longevity Toolkit
In 2023, the longevity community was jolted by a paper in Science demonstrating that a cheap, widely available amino acid called taurine extended the median lifespan of mice by ten to twelve percent and improved healt…
